Drägerwerk AG & Co. KGaA

BATS-CHIXE:DRW3D Stock Report

Market Cap: €771.5m

Drägerwerk KGaA Past Earnings Performance

Past criteria checks 0/6

Drägerwerk KGaA's earnings have been declining at an average annual rate of -6.8%, while the Medical Equipment industry saw earnings declining at 9.5% annually. Revenues have been growing at an average rate of 5.2% per year.

Key information

-6.8%

Earnings growth rate

-4.9%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate5.2%
Return on equity-1.5%
Net Margin-0.7%
Next Earnings Update27 Jul 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Drägerwerk KGaA makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BATS-CHIXE:DRW3D Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 233,157-21983345
31 Dec 223,045-65981343
30 Sep 222,953-149982351
30 Jun 222,997-83968347
31 Mar 223,18625958339
31 Dec 213,328134938329
30 Sep 213,518224945311
30 Jun 213,611274930298
31 Mar 213,558278909294
31 Dec 203,406189912290
30 Sep 203,173171877278
30 Jun 202,97394869275
31 Mar 202,81929861268
31 Dec 192,78125848264
30 Sep 192,76548827255
30 Jun 192,71539816253
31 Mar 192,70144814253
31 Dec 182,59526797252
30 Sep 182,56416795255
30 Jun 182,57237791251
31 Mar 182,53346770241
31 Dec 172,57274770235
30 Sep 172,55673769227
30 Jun 172,52870767221
31 Mar 172,52674765221
31 Dec 162,52461768219
30 Sep 162,53048812220
30 Jun 162,54117831226
31 Mar 162,59615856229
31 Dec 152,60925868231
30 Sep 152,55346818232
30 Jun 152,54190797223
31 Mar 152,46785775218
31 Dec 142,43597750212
30 Sep 142,38394742206
30 Jun 142,34785732205
31 Mar 142,354101733203
31 Dec 132,374115745202
30 Sep 132,383113754203
30 Jun 132,401120756203
31 Mar 132,378124755200
31 Dec 122,373127743197
30 Sep 122,345126752190
30 Jun 122,295125747178

Quality Earnings: DRW3D is currently unprofitable.

Growing Profit Margin: DRW3D is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: DRW3D is unprofitable, and losses have increased over the past 5 years at a rate of 6.8% per year.

Accelerating Growth: Unable to compare DRW3D's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: DRW3D is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-12.2%).


Return on Equity

High ROE: DRW3D has a negative Return on Equity (-1.46%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.